Currently predicting for Mon, 1 Apr 2024

Trading levels for GILD

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 74.11 1.17 %
R2 73.85 0.82 %
R1 73.70 0.609 %
Current price: 73.25
Support S1 73.18 -0.0900 %
S2 73.03 -0.306 %
S3 72.77 -0.655 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 78.43 7.07 %
R2 74.42 1.60 %
R1 73.69 0.601 %
Current price 73.25
Support S1 73.01 -0.328%
S2 72.10 -1.57%
S3 71.58 -2.28%

GILD Predictions History

2 years ago
AlexVel predicted that GILD for 2022-03-07 is going $61.58 (2.19%)

2 years ago
JS predicted that GILD for 2022-03-07 is going $61.52 (-0.55%)

2 years ago
matorimu predicted that GILD for 2022-03-07 is going $67.11 (8.49%)

Rank:

2 years ago
SebastianRyszkiewicz predicted that GILD for 2021-08-31 is going $73.00 (0.30%)

Rank:

2 years ago
RamboRex3000 predicted that GILD for 2021-08-30 is going $72.42 (0.57%)

2 years ago
JS predicted that GILD for 2021-08-30 is going $71.07 (-1.31%)

2 years ago
vnpigunov1 predicted that GILD for 2021-08-30 is going

Rank:

2 years ago
RamboRex3000 predicted that GILD for 2021-07-29 is going $69.95 (0.17%)

2 years ago
JS predicted that GILD for 2021-07-29 is going $70.56 (1.05%)

2 years ago
beckymac_photography predicted that GILD for 2021-07-29 is going $71.55 (2.46%)

Rank:
Click to get the best stock tips daily for free!

About Gilead Sciences

Gilead Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, an injection for intravenous use, for the treatment of coronavirus disease 2019; and Epclusa, Harvoni, V... GILD Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT